Akari Therapeutics
AKTX
9 hedge funds and large institutions have $377K invested in Akari Therapeutics in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
4% less capital invested
Capital invested by funds: $394K → $377K (-$16.5K)
18% less funds holding
Funds holding: 11 → 9 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$139 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCG
Catalina Capital Group
Torrance,
California
|
-$16K |
| 2 |
Renaissance Technologies
New York
|
-$5.88K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$237 |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$122 |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
-$6 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAI
1
Palo Alto Investors
Palo Alto,
California
| $181K | – | – | – |
|
|
OFW
2
Omnia Family Wealth
Aventura,
Florida
| $109K | – | – | – |
|
3
Cerity Partners
New York
| $29.3K | – | – | – |
|
|
CAM
4
Cresset Asset Management
Chicago,
Illinois
| $22.8K | – | – | – |
|
|
5
Renaissance Technologies
New York
| $22.8K | -$5.88K | -127 | -22% |
|
|
ACM
6
Accent Capital Management
Centerville,
Ohio
| $12.4K | – | – | – |
|
7
Bank of America
Charlotte,
North Carolina
| $186 | – | – | – |
|
|
TC
8
Truvestments Capital
Sarasota,
Florida
| $62 | – | – | – |
|
|
CPG
9
Cornerstone Planning Group
Fairfield,
New Jersey
| $7 | – | – | – |
|
10
Morgan Stanley
New York
| $7 | – | – | – |
|
|
CCG
11
Catalina Capital Group
Torrance,
California
| – | -$16K | -328 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$237 | -5 | Closed |
|
|
13
Osaic Holdings
Scottsdale,
Arizona
| – | -$122 | -3 | Closed |
|
|
SS
14
SBI Securities
Tokyo,
Japan
| – | -$6 | – | – |
|
|
15
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$139 | +3 | New |
|
AKTX Hedge Fund Activity: Q1 2025 in Review
9 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in Akari Therapeutics (AKTX) for Q1 2025, worth a combined $377K — down 4.2% from $394K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of AKTX and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Royal Bank of Canada, opening a new position worth an estimated $139. The largest seller was Catalina Capital Group, exiting entirely with an estimated $16K sold.
- 9 institutional investors held Akari Therapeutics (AKTX) as of Q1 2025, down from 11 in Q4 2024.
- Funds reported $377K of Akari Therapeutics stock for Q1 2025, down 4.2% quarter-over-quarter.
- 1 fund opened new Akari Therapeutics positions in Q1 2025 and 3 closed out, a net change of -2 holders.
- The largest Akari Therapeutics buyer in Q1 2025 was Royal Bank of Canada, an estimated $139 added.
- The largest Akari Therapeutics seller in Q1 2025 was Catalina Capital Group, an estimated $16K sold.
Based on aggregated 13F filings for Q1 2025.